Nemes Rush Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.8M Buy
70,524
+3,263
+5% +$969K 1.98% 12
2025
Q4
$18.4M Sell
67,261
-360
-0.5% -$97.8K 1.73% 17
2025
Q3
$18.3M Buy
67,621
+498
+0.7% +$135K 1.81% 16
2025
Q2
$18.5M Buy
67,123
+302
+0.5% +$82.1K 2.01% 13
2025
Q1
$17.7M Buy
66,821
+1,439
+2% +$355K 2.24% 11
2024
Q4
$15.2M Buy
65,382
+4,609
+8% +$1.06M 1.88% 13
2024
Q3
$13.1M Sell
60,773
-2,802
-4% -$580K 1.9% 15
2024
Q2
$12.5M Buy
63,575
+2,167
+4% +$448K 1.72% 17
2024
Q1
$13.2M Buy
61,408
+2,815
+5% +$591K 1.89% 16
2023
Q4
$12.3M Buy
58,593
+629
+1% +$134K 1.99% 12
2023
Q3
$11.6M Buy
57,964
+2,436
+4% +$484K 2.1% 12
2023
Q2
$10.3M Buy
+55,528
New +$10.3M 1.81% 15

Other funds holding CME

Nemes Rush Group's CME Position: Q1 2026 in Review

Nemes Rush Group increased its CME Group (CME) stake by 4.9% in Q1 2026, buying an estimated $969K and bringing the position to 70,524 shares worth $20.8M. The position accounts for 1.98% of the portfolio, ranked #12.

Nemes Rush Group first reported a position in CME in Q2 2023 and has held it in 12 quarters since. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Nemes Rush Group held 70,524 shares of CME Group worth $20.8M as of Q1 2026.
  • Nemes Rush Group bought 3,263 CME Group shares in Q1 2026, an estimated $969K.
  • CME Group made up 1.98% of Nemes Rush Group's portfolio in Q1 2026, its #12 holding.
  • Nemes Rush Group first reported a position in CME Group in Q2 2023 and has held it in 12 quarters since.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.